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Abstract The effect of v9-tetrahydrocannabinol (THC), the
major psycho-active component of marijuana, in human prostate
cancer cells PC-3 was investigated. THC caused apoptosis in a
dose-dependent manner. Morphological and biochemical changes
induced by THC in prostate PC-3 cells shared the characteristics
of an apoptotic phenomenon. First, loss of plasma membrane
asymmetry determined by fluorescent anexin V binding. Second,
presence of apoptotic bodies and nuclear fragmentation observed
by DNA staining with 4P,6-diamino-2-phenylindole (DAPI).
Third, presence of typical ‘ladder-patterned’ DNA fragmenta-
tion. Central cannabinoid receptor expression was observed in
PC-3 cells by immunofluorescence studies. However, several
results indicated that the apoptotic effect was cannabinoid
receptor-independent, such as lack of an effect of the potent
cannabinoid agonist WIN 55,212-2, inability of cannabinoid
antagonist AM 251 to prevent cellular death caused by THC and
absence of an effect of pertussis toxin pre-treatment.
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1. Introduction
Marijuana cannabinoids exert a wide spectrum of psycho-
active and immuno-active e¡ects, such as the coordination of
movement, short-term memory and titration of mood and
emotions. Cannabinoids have also been shown to be involved
in immune homeostasis and control [1]. It is known that can-
nabinoids bind receptors in the brain and that these receptors
appear also to be in tissues outside the central nervous system.
Two cannabinoid receptor subtypes have been identi¢ed, des-
ignated CB1 and CB2 [2]. CB1 is predominantly expressed in
brain although it has also been detected in reproductive or-
gans such as uterus [3] and testis [4], while CB2 has been
predominantly found in immune tissues. Cannabinoids bind-
ing to receptor inhibits adenylate cyclase and the accumula-
tion of cAMP. In contrast, cannabinoid activation of arach-
idonic acid release by stimulation of phospholipase C and
release of the calcium concentration from intracellular stores
are receptor-independent e¡ects. The availability of the major
active psychotropic component of marijuana, v9-tetrahydro-
cannabinol (THC), in its pure form and the recent discovery
of the endogenous ligand for cannabinoids receptors [5] have
generated a lot of studies on cannabinoids and their cellular
e¡ects. Cannabinoids have been shown to induce apoptosis in
mononuclear cells [6], macrophages, lymphocytes [7] and glial
cells [8] and they activate cell growth in hematopoietic cell
lines [9]. However, few studies have been performed in tissues
outside the central nervous system and immune cells. The
e¡ects of cannabinoids in peripheral tissues remain still un-
elucidated. Although endogenous cannabinoids, like anand-
amide, are principally synthesized in brain, recent reports in-
dicate that they are also produced in testis [10]. The fact that
anandamide is produced in testis and that CB1 receptor is also
expressed in reproductive organs prompted us to investigate
the e¡ect of cannabinoids in prostate cells.
The in vitro study of prostate cancer has been limited by
the availability of cell lines. Both normal and tumor-derived
prostate epithelial cells have been extremely di⁄cult to growth
in culture. PC-3 cells are an androgen refractory human epi-
thelial cell line derived from a prostatic metastasis to the
bone. In this study, we have observed that THC induces
apoptosis in PC-3 cells. The cannabinoid e¡ect was compared
to that produced by ceramide, used as positive control for
apoptotic induction.
Cells undergoing apoptosis display several morphological
and biochemical alterations, including a reduced cellular vol-
ume, condensed chromatin in the nucleus, changes in the dis-
tribution of plasma membrane phospholipids and cleavage of
chromatin into oligonucleosome length DNA fragments
(‘DNA ladders’) by nuclease, although this fragmentation of
internal nucleosomal DNA is not always present in apoptotic
cells [11]. The biochemical signals that regulate apoptosis are
not well de¢ned but recent evidence has implicated ceramide
as an important second messenger regulating cell death [12] as
well as other stress responses like induction of nerve growth
factor synthesis by astrocytes [13]. Ceramide has been shown
to activate several kinases and phosphatases including the
j isoform of protein kinase C (PKC j) [14]. Ceramide is gen-
erated from sphingomyelin hydrolysis by a PLC-type sphin-
gomyelinase. Sphingomyelin breakdown has been shown to
occur in multiple cell types in response to a variety of extra-
cellular mediators and play an important role in the regula-
tion of cell death, di¡erentiation and senescence. In prostate
cells, ceramide has been shown to mediate apoptosis induced
by suramin [15] and by PKC [16].
2. Materials and methods
2.1. Materials
THC and 3-4,5-dimethylthiazole-2,5-diphenyltetrazolium bromide
thiazole blue (MTT) were from Sigma (St. Louis, USA). WIN
55,212-2 and AM 251 were from Tocris (Bristol, UK). D-Erythro-N-
acetylsphingosine (C2-ceramide), 4P,6-diamino-2-phenylindole (DAPI)
and annexin V-FITC were from Calbiochem (La Jolla, CA, USA).
Anti-cannabinoid CB1 receptor polyclonal antibody was from Chem-
icon International (Temecula, CA, USA). Fluorescein-conjugated
donkey anti-rabbit IgG was from Amersham (Little Chaltfont, UK).
Other agents were from Sigma (St. Louis, USA).
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2.2. Cell cultures
PC-3 cells were routinely grown in RPMI 1640 medium supple-
mented with 10% fetal calf serum. 24 h before the experiment, the
serum-containing medium was removed and cells were transferred to a
chemically de¢ned medium consisting of RPMI 1640 supplemented
with 5 Wg/ml insulin, 5 Wg/ml transferrin and 5 ng/ml sodium selenite.
2.3. MTT assay
After treatment, cells were incubated with 5 Wg/ml MTT for 1 h at
37‡C and then, formazan crystals were solubilized by addition of 60
mM HCl in isopropanol for 24 h at 37‡C. The absorbance at 570 and
630 nm was then monitored.
2.4. Anexin V-FITC binding
Cells were grown in glass coverslips and were made quiescent by
serum starvation. After treatment, cells were washed in phosphate-
bu¡ered saline (PBS) and then with binding bu¡er (50 mM HEPES
pH 7.4, 750 mM NaCl, 12.5 mM CaCl2, 5 mM MgCl2 and 20% BSA).
Recombinant anexin V conjugated with £uorescein isothiocyanate
(200 Wg/ml) was then added for 30 min. After washing with binding
bu¡er, 10 Wl propidium iodide (PI) was added and then, cells were
observed by £uorescence microscopy [17].
2.5. DAPI staining of nuclei
Morphological changes in the nuclear chromatin of cells under-
going apoptosis were detected by staining with the DNA binding
£uorochrome DAPI. PC-3 cells were grown in glass coverslips and
after treatment, coverslips were incubated with a drop of 1 Wg/ml
DAPI for 20 min. Coverslips were then washed in PBS, mounted
with Vectashield (Vector Laboratories, Burlingame, CA, USA) and
subjected to £uorescence microscopy.
2.6. DNA fragmentation
DNA from prostate cancer PC-3 cells was prepared by modi¢cation
of a previous method [18]. Cells were cultured in plates and treated
according to the experiment. After treatment, cells (£oating plus at-
tached) were washed in PBS and pelleted. Cells were lysed in 250 Wl of
STE (250 mM sucrose, 5 mM Tris-HCl, pH 8.0, 1 mM EDTA), 1.56
ml TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) and 125 Wl 25% (w/v)
sodium dodecyl sulfate overnight at 37‡C. After treatment with 50 Wg/
ml RNAse A for 1 h at 37‡C, 8 M potassium acetate was added to
obtain a ¢nal concentration of 1.33 M and then lysate was extracted
with chloroform:isoamyl alcohol (24:1). DNA was precipitated from
the aqueous phase with ethanol and an aliquot containing 4 Wg DNA
was subjected to electrophoresis in 2% agarose gels.
2.7. Immuno£uorescence of CB1 receptor
PC-3 cells were seeded in glass coverslips and grown in serum-con-
taining medium for 2 days. Afterwards, coverslips were washed in
PBS and immersed in 3.7% formaldehyde for 5 min after which
they were rinsed in PBS and subsequently incubated in 0.05% Triton
X-100 for 5 min. After washing in PBS, coverslips were incubated
with rabbit anti-cannabinoid CB1 receptor (1:10 dilution) for 120
min in a humid chamber. Afterwards, coverslips were rinsed exten-
sively in PBS and incubated with the secondary antibody £uorescein-
conjugated anti-rabbit IgG (1:25 dilution) for 60 min. Coverslips were
then washed in PBS, mounted with Vectashield and observed by £uo-
rescence microscopy.
3. Results and discussion
3.1. THC and C2-ceramide induce apoptosis in prostate PC-3
cells
The study of the action of cannabinoids in prostate tumor
cells was initiated by analyzing the e¡ect of the major active
component of marijuana, THC, in PC-3 cells viability. PC-3
cells were treated with di¡erent doses of THC and cellular
viability was determined by the ability of cells to hydrolyze
tetrazolium salts, which is dependent on mitochondrial oxida-
tive metabolism. Treatment of cells with THC resulted in a
dramatic drop of cellular viability in a dose-dependent man-
ner (Fig. 1A). Cell death occurred after 2^3 days of the addi-
tion of THC and a maximal e¡ect was observed at 6 days
Fig. 1. Inhibition of human prostate PC-3 cells mitochondrial oxida-
tive metabolism by THC. A: Cells were cultured in serum-free me-
dium in the presence of increasing concentrations of THC for 3
days. B: Cells were cultured in serum-free medium in the absence
(a) or presence (b) of 1 WM THC for the times indicated. Each
point represents triplicate determinations and results are based on
at least three independent experiments.
Fig. 2. Inhibition of human prostate PC-3 cells mitochondrial oxida-
tive metabolism by C2-ceramide. Cells were incubated in serum-free
medium in the presence of increasing concentrations of C2-ceramide
for 3 days. Each point represents triplicate determinations and re-
sults are based on two independent experiments.
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Fig. 4. Nuclear fragmentation observed by DNA staining with DAPI. A: Human prostate PC-3 cells were cultured in serum-free medium and
exposed to vehicle, 1 WM THC, 10 WM TCH and 10 WM C2-ceramide and stained with DAPI. Condensed and fragmented nuclei (arrow) were
observed in cells treated with THC and with C2-ceramide. Micrographs are representatives of three independent experiments (bar = 10 Wm).
B: Quantitative analysis of three independent experiments. Signi¢cantly di¡erent (*P6 0.05, **P6 0.01) versus incubation with vehicle.
Fig. 3. Anexin V-FITC binding to PC-3 cells. Cells were cultured in serum-free medium and treated for 6 days with A: DMSO (0.1%), B:
1 WM THC, C: 10 WM C2-ceramide. Micrographs are representative of three independent experiments (bar = 10 Wm).
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(Fig. 1B). We then compared the e¡ect produced by THC
with that induced by ceramide, which has been shown to in-
duce apoptosis in many cells including prostate cells [15]. In
our cell type, addition of the short chain cell-permeable ana-
log of ceramide, C2-ceramide, also reduced the cellular viabil-
ity. The e¡ect was maximal at 10 WM C2-ceramide (Fig. 2).
An early and critical event in apoptosis involves changes on
the cell surface as exposure of phosphatidylserine that can be
detected by binding of £uorescent annexin V. To characterize
the cellular death process caused by THC, PC-3 cells were
treated with the agent and binding of FITC-annexin V was
detected by £uorescence microscopy. A simultaneous label of
cellular DNA with PI was performed to discriminate between
apoptotic cells (FITC/PI3) and necrotic cells (FITC/PI)
[15] (data not shown). Results revealed that treatment with
10 WM THC and 10 WM ceramide induce changes in plasma
membrane asymmetry from 3 days and were maintained until
6 days, assessed by an increase in membrane £uorescence (Fig.
3 and data not shown).
To further analyze whether the reduction in cell viability by
THC and ceramide is due to apoptosis, PC-3 cells were
treated with 1 WM THC, 10 WM THC and 10 WM C2-ceramide
for di¡erent days and then, cells were stained with DAPI,
which enters the cells and binds to fragmented DNA. Nuclear
changes were observed by £uorescence microscopy. Results in
Fig. 4A show apoptotic bodies in cells treated with THC and
C2-ceramide but not in control cells. Quantitative analysis is
shown in Fig. 4B. THC induced a dose-response increase in
apoptotic cells. The increase is higher than that observed in
ceramide-treated cells used as a positive control (Fig. 4).
To con¢rm whether THC induced internucleosomal cleav-
age of DNA, DNA from treated cells was isolated and re-
solved by agarose electrophoresis. THC induces a dose-de-
pendent DNA fragmentation into typical 180 bp multiples,
giving rise to the ladder pattern characteristic of cell death
by apoptosis (Fig. 5). Ceramide-treated cells also showed
the ladder pattern (Fig. 5).
Results shown here indicate that the cellular death process
induced by THC in prostate tumor cells PC-3 shares the bio-
chemical and morphological changes characteristic of apop-
totic cells. These changes are comparable to those induced by
ceramide.
3.2. THC-induced apoptosis in PC-3 cells occurs via
a receptor-independent pathway
THC binds to two types of receptors, CB1 and CB2, which
inhibit adenylate cyclase via a pertussis toxin (PTX)-sensitive
G protein. CB1 receptor mRNA has been described in human
Fig. 5. DNA fragmentation induced by THC and C2-ceramide. Hu-
man prostate PC-3 cells were exposed to vehicle, 1 WM THC, 10 WM
TCH and 10 WM C2-ceramide for 7 days. The result shown is a
representative of four other independent experiments.
Fig. 6. Immuno£uorescence of cannabinoid receptor CB1 in human prostate PC-3 cells. The micrograph shown is a representative of two other
experiments (bar = 5 Wm).
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prostate [19] although receptor protein has not been charac-
terized in prostate. Immuno£uorescence studies show that
CB1 receptor is expressed in PC-3 cells (Fig. 6). Therefore,
we then studied whether the apoptosis induced by THC in
prostate PC-3 cells was mediated by this receptor. We ¢rst
analyzed the e¡ect of the potent synthetic ligand aminoalkyn-
dole, WIN 55,212-2 [19], which displays a high a⁄nity for
both cannabinoid receptors. Neither 0.5 nor 1 WM WIN
55,212-2 had any e¡ect on PC-3 cell viability (Fig. 7). More-
over, the e¡ect produced by THC was not prevented by the
antagonist AM 251 (Fig. 6). This results suggests a receptor-
independent mechanism for THC-induced apoptosis in PC-3
prostate cells. Cannabinoid receptors are coupled to a hetero-
trimeric Gi protein that can be inactivated by pre-treatment
with PTX. We therefore compared the apoptotic e¡ect of
THC in the presence or absence of PTX. Pre-treatment of
PC-3 cells with 100 ng/ml PTX had no e¡ect on apoptosis
induced by THC (Fig. 8), reinforcing the notion of a canna-
binoid receptor-independent phenomenon.
Thus, in this study, we have shown that the major active
component of marijuana, THC, induced prostate PC-3 cell
death by an apoptotic process. The apoptotic death caused
by THC treatment was even higher than that produced by
ceramide. In spite of the presence of cannabinoid receptor
CB1 in prostate PC-3 cells, THC exerts its action via a non-
receptor-mediated pathway. Our results are in concordance
with previous studies which demonstrate in other cell types,
a cannabinoid induction of apoptosis by a receptor-independ-
ent mechanism [7,8]. Cannabinoids also regulate hemato-
poietic cell growth independently of receptor [9]. Whatever
the precise mechanism underlying the non-receptor-mediated
e¡ects of cannabinoids, these molecules regulate fundamental
cellular functions like proliferation and cell death. The apop-
totic e¡ect of THC described in this study might provide the
basis for future therapeutic application of cannabinoids. Fur-
ther studies will determinate whether cannabinoids exert other
e¡ects in prostate cells.
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Fig. 7. Comparison of THC and WIN 55,212-2 on mitochondrial
oxidative metabolism e¡ect. PC-3 cells were incubated in the pres-
ence of 5 WM THC, 5 WM THC plus 5 WM AM 251 or di¡erent
doses of WIN 55,212-2 for 3 days and mitochondrial oxidative me-
tabolism was determinated by a MTT assay. Each point represents
triplicate determinations and results are based on two independent
experiments. *, Signi¢cantly di¡erent (P6 0.05) versus incubations
with vehicle.
Fig. 8. Absence of an e¡ect of PTX on THC-induced cell death.
PC-3 cells were cultured in serum-free medium, pre-incubated for 30
min with 100 ng/ml PTX and treated with di¡erent doses of THC
for 3 days. Mitochondrial oxidative metabolism was determinate by
a MTT assay. Each point represents triplicate determinations and
results are based on two independent experiments.
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